News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
99 Results
Type
Article (10)
Press Release (89)
Section
Business (25)
Deals (4)
Drug Development (21)
Job Trends (1)
News (39)
Policy (1)
Tag
Academia (1)
Alliances (6)
Best Places to Work (1)
Cancer (2)
Clinical research (19)
Collaboration (1)
Data (2)
Diagnostics (1)
Earnings (1)
ESMO (1)
Events (21)
Funding (3)
Healthcare (1)
Intellectual property (1)
IPO (2)
Manufacturing (2)
Medical device (1)
Medtech (1)
Mergers & acquisitions (3)
NextGen: Class of 2026 (1)
People (13)
Phase 1 (8)
Phase 2 (12)
Phase 3 (8)
Pipeline (3)
Postmarket research (1)
Real estate (1)
Regulatory (2)
Startups (3)
Venture capital (1)
Date
Last 30 days (1)
Last 365 days (7)
2026 (7)
2025 (6)
2024 (7)
2023 (12)
2022 (9)
2021 (11)
2020 (13)
2019 (14)
2018 (6)
2017 (5)
2016 (2)
2015 (5)
2014 (2)
Location
Asia (13)
California (14)
Europe (5)
Southern California (14)
United States (14)
99 Results for "rakuten aspyrian".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rakuten Medical Presents Long-Term Follow-up Results of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for R/M HNSCC at ESMO 2026
October 23, 2026
·
5 min read
Press Releases
Rakuten Medical Appoints Christophe Weber as Vice Chairman and Ken Takeshita, M.D., as Director to Accelerate U.S. Growth and Oncology Innovation
September 9, 2026
·
6 min read
Press Releases
Rakuten Medical Announces Executive Leadership Transition to Enhance Operational Execution and Organizational Discipline as a Global, Scalable Biotech Company
June 10, 2026
·
7 min read
Press Releases
Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program
January 14, 2026
·
5 min read
Press Releases
Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
January 7, 2026
·
10 min read
Press Releases
Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
January 21, 2026
·
6 min read
Press Releases
Rakuten Medical Selected to Participate in FDA CEO Forum in San Diego
June 16, 2025
·
5 min read
Biotech Bay
Rakuten Aspyrian Announces Name Change to Rakuten Medical
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, announced that it has changed its name to Rakuten Medical, Inc.
March 1, 2019
·
5 min read
Press Releases
Rakuten Medical’s Anti-PD-L1 Antibody-IR700 Conjugate, RM-0256, Selected for AMED Funding
June 5, 2025
·
7 min read
Biotech Beach
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
Rakuten Medical, Inc today announced that it will present a poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (ASCO 2024), which will be held in Chicago, Illinois from May 31 through June 4, 2024.
May 9, 2024
·
5 min read
1 of 10
Next
